Ian Durrant
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Anthony H. GoldstoneSusan RichardsMark R. LitzowAndrew McMillanAdele K. FieldingHillard M. LazarusMartin S. TallmanDavid I. Marks
- Journals
- British Journal of Haematology (4 papers)Blood (2 papers)Hematology/Oncology Clinics of North America (1 paper)Clinical Chemistry (1 paper)Journal of Histochemistry & Cytochemistry (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Ian Durrant
21 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Hematology 691
- Public Health, Environmental and Occupational Health 774
- Genetics 153
- Pediatrics, Perinatology and Child Health 224
- Oncology 305
Countries citing papers authored by Ian Durrant
This map shows the geographic impact of Ian Durrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Durrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Durrant more than expected).
Fields of papers citing papers by Ian Durrant
This network shows the impact of papers produced by Ian Durrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Durrant. The network helps show where Ian Durrant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ian Durrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 201 | |
| 2 | Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study Hit paper breakdown → | 2006 | 591 |
| 3 | 2003 | 0 | |
| 4 | 2003 | 3 | |
| 5 | 2003 | 3 | |
| 6 | 2003 | 2 | |
| 7 | 2003 | 0 | |
| 8 | 2000 | 31 | |
| 9 | 1997 | 2 | |
| 10 | 1996 | 5 | |
| 11 | 1996 | 8 | |
| 12 | 1996 | 3 | |
| 13 | 1995 | 10 | |
| 14 | 1995 | 4 | |
| 15 | 1993 | 28 | |
| 16 | 1991 | 3 | |
| 17 | 1991 | 6 | |
| 18 | 1990 | 68 | |
| 19 | 1986 | 8 | |
| 20 | 1976 | 66 |
About Ian Durrant
Ian Durrant is a scholar working on Hematology, Microbiology, Public Health, Environmental and Occupational Health, Modeling and Simulation and Molecular Biology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (7 papers), DNA and Nucleic Acid Chemistry (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Click Chemistry and Applications (3 papers), Acute Myeloid Leukemia Research (3 papers), Chemical Synthesis and Analysis (3 papers), Molecular Biology Techniques and Applications (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Hematology (691 citations), Public Health, Environmental and Occupational Health (774 citations), Genetics (153 citations), Pediatrics, Perinatology and Child Health (224 citations) and Oncology (305 citations). Ian Durrant has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Anthony H. Goldstone, Susan Richards, Mark R. Litzow, Andrew McMillan, Adele K. Fielding, Hillard M. Lazarus, Martin S. Tallman, David I. Marks, Selina M. Luger and Jacob M. Rowe. Their work appears in journals such as British Journal of Haematology, Blood, Hematology/Oncology Clinics of North America, Clinical Chemistry and Journal of Histochemistry & Cytochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.